Pulmonary Hypertension Association Endorses CHEST Guidelines for Treatment of Pulmonary Arterial Hypertension in Adults

PHA has endorsed the American College of Chest Physicians guidelines for the management and treatment of pulmonary arterial hypertension in adults.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

Pulmonary Hypertension Association

“These guidelines help physicians understand the broad range of therapies available and the need for more research to create more." - Rino Aldrighetti, PHA President and CEO

Silver Spring, Md. (PRWEB) August 27, 2014

The American College of Chest Physicians(CHEST) recently released guidelines for the management and treatment of pulmonary arterial hypertension (PAH) in adults, Pharmacological Therapy for Pulmonary Arterial Hypertension in Adults: CHEST Guideline, in the journal CHEST. The guidelines are free to view for clinicians, and provide the latest and most accurate treatment guidelines for PAH.

The Pulmonary Hypertension Association (PHA) – the country’s leading pulmonary hypertension association that works to find ways to prevent and cure pulmonary hypertension – endorses these guidelines and sees them as a step in the right direction. Pulmonary hypertension is a disease of the lungs that affects the functioning of the heart and can lead to right heart failure. Without treatment, mean survivability is only 2.8 years.

“Many times physicians are not clearly informed on the latest ways to treat PAH,” said Rino Aldrighetti, PHA President and CEO. “These guidelines help physicians understand the broad range of therapies available and the need for more research to create more.”

Pharmacological Therapy for Pulmonary Arterial Hypertension in Adults: CHEST Guideline and Expert Panel Report provides 79 recommendations and expert consensus statements aimed at assisting physicians in the management of PAH using the latest drug therapies. The complete guidelines are available in CHEST Journal. The guidelines were reviewed and endorsed by the PHA Scientific Leadership Council.

About the Pulmonary Hypertension Association
Headquartered in Silver Spring, Md., the Pulmonary Hypertension Association (PHA) is the country's leading pulmonary hypertension organization. Its mission is to find ways to prevent and cure pulmonary hypertension and provide hope for the community through support, education, research, advocacy and awareness. PHA does this by connecting and working together with the entire PH community of patients, families and medical professionals. PHA facilitates more than 245 support groups around the country and delivers continuing education for medical professionals.


Contact